Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference
WOBURN, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) —
Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that Erica Monaco, Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference being held at the Yale Club in New York City on October 6, 2022. Management will…
On October 6, 2022, Erica Monaco, CEO of Biofrontera Inc., will be presenting at the Roth Inaugural Healthcare Opportunities Conference in New York City. This is a great opportunity for the company to showcase their expertise in dermatological products.
How will this affect me?
As a consumer, this presentation could potentially introduce new dermatological products to the market that may benefit your skincare routine. It’s always exciting to see advancements in the medical field that could improve our overall health and well-being.
How will this affect the world?
With Biofrontera Inc. presenting at such a prestigious conference, it could lead to more awareness and interest in dermatological research and development. This could ultimately result in groundbreaking discoveries that have a positive impact on global health and skincare practices.
Conclusion
Overall, Biofrontera Inc.’s presentation at the Roth Inaugural Healthcare Opportunities Conference is a promising opportunity for both the company and the world of dermatology. It signifies a step forward in advancing medical research and innovation, with potential benefits for individuals and society as a whole.
